Ramadoss S, Qin J, Tao B, Thomas N, Cao E, Wu R
Nat Cardiovasc Res. 2024; 3(11):1356-1373.
PMID: 39455836
DOI: 10.1038/s44161-024-00555-4.
Liu Y, Pang J, Zhang C, Zeng L, Wang Y, Wang S
Heliyon. 2024; 10(17):e36574.
PMID: 39263169
PMC: 11388787.
DOI: 10.1016/j.heliyon.2024.e36574.
Patsalos A, Halasz L, Oleksak D, Wei X, Nagy G, Tzerpos P
J Clin Invest. 2024; 134(20).
PMID: 39190487
PMC: 11473166.
DOI: 10.1172/JCI173858.
Vakayil M, Madani A, Agha M, Majeed Y, Hayat S, Yonuskunju S
Sci Rep. 2024; 14(1):11886.
PMID: 38789534
PMC: 11126700.
DOI: 10.1038/s41598-024-62508-y.
Gibbons E, Taya M, Wu H, Lopa S, Moss J, Henske E
Endocr Relat Cancer. 2024; 31(6).
PMID: 38614127
PMC: 11103253.
DOI: 10.1530/ERC-23-0312.
Single-cell transcriptome sequencing-based analysis: probing the mechanisms of glycoprotein NMB regulation of epithelial cells involved in silicosis.
Yang S, Sun Y, Long M, Zhou X, Yuan M, Yang L
Part Fibre Toxicol. 2023; 20(1):29.
PMID: 37468937
PMC: 10354944.
DOI: 10.1186/s12989-023-00543-9.
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis.
Palisoc P, Vaikutis L, Gurrea-Rubio M, Model E, Omara M, Ory S
Front Immunol. 2022; 13:814533.
PMID: 35280996
PMC: 8907428.
DOI: 10.3389/fimmu.2022.814533.
Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins.
Chrystal P, Footz T, Hodges E, Jensen J, Walter M, Allison W
Molecules. 2021; 26(12).
PMID: 34207849
PMC: 8273697.
DOI: 10.3390/molecules26123529.
The Role of GPNMB in Inflammation.
Saade M, de Souza G, Scavone C, Kinoshita P
Front Immunol. 2021; 12:674739.
PMID: 34054862
PMC: 8149902.
DOI: 10.3389/fimmu.2021.674739.
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.
Aichholzer F, Klafki H, Ogorek I, Vogelgsang J, Wiltfang J, Scherbaum N
Alzheimers Res Ther. 2021; 13(1):94.
PMID: 33947460
PMC: 8097817.
DOI: 10.1186/s13195-021-00828-1.
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.
Liguori M, Digifico E, Vacchini A, Avigni R, Colombo F, Borroni E
Cell Mol Immunol. 2020; 18(3):711-722.
PMID: 32728200
PMC: 8027814.
DOI: 10.1038/s41423-020-0501-0.
Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.
Tsou P, Sawalha A
FASEB J. 2020; 34(7):8810-8823.
PMID: 32445534
PMC: 7501235.
DOI: 10.1096/fj.202000651.
Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease.
Satoh J, Kino Y, Yanaizu M, Ishida T, Saito Y
Intractable Rare Dis Res. 2019; 8(2):120-128.
PMID: 31218162
PMC: 6557242.
DOI: 10.5582/irdr.2019.01049.
Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.
van der Lienden M, Gaspar P, Boot R, Aerts J, van Eijk M
Int J Mol Sci. 2018; 20(1).
PMID: 30586924
PMC: 6337583.
DOI: 10.3390/ijms20010066.
Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans.
Lin L, Chun Chang S, OHearn J, Hui S, Seldin M, Gupta P
G3 (Bethesda). 2018; 8(11):3499-3506.
PMID: 30201759
PMC: 6222577.
DOI: 10.1534/g3.118.200655.
Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding.
Waldera-Lupa D, Etemad-Parishanzadeh O, Brocksieper M, Kirchgaessler N, Seidel S, Kowalski T
Oncotarget. 2018; 8(66):110118-110132.
PMID: 29299134
PMC: 5746369.
DOI: 10.18632/oncotarget.22654.
GPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response.
Noda Y, Tsuruma K, Takata M, Ishisaka M, Tanaka H, Nakano Y
Sci Rep. 2017; 7(1):12160.
PMID: 28939899
PMC: 5610265.
DOI: 10.1038/s41598-017-11828-3.
Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Arosarena O, Barr E, Thorpe R, Yankey H, Tarr J, Safadi F
J Cell Physiol. 2017; 233(1):409-421.
PMID: 28295306
PMC: 5592128.
DOI: 10.1002/jcp.25900.
Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.
Murugesan V, Liu J, Yang R, Lin H, Lischuk A, Pastores G
Blood Cells Mol Dis. 2016; 68:47-53.
PMID: 28003098
PMC: 5468511.
DOI: 10.1016/j.bcmd.2016.12.002.
Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling.
Sondag G, Mbimba T, Moussa F, Novak K, Yu B, Jaber F
Exp Mol Med. 2016; 48(9):e257.
PMID: 27585719
PMC: 5050297.
DOI: 10.1038/emm.2016.78.